<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03890835</url>
  </required_header>
  <id_info>
    <org_study_id>CEBD-CU-2019-03-10</org_study_id>
    <nct_id>NCT03890835</nct_id>
  </id_info>
  <brief_title>Pulpotomy in Mature Permanent Molars Using Biodentine Versus MTA</brief_title>
  <official_title>Comparative Evaluation of Postoperative Pain and Success Rate After Pulpotomy in Mature Permanent Molars Using Biodentine Versus Mineral Trioxide Aggregate (MTA) as Capping Materials: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare treatment outcomes of pulpotomy in mature permanent teeth
      using Biodentine versus MTA regarding postoperative pain and success rate.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Patients will be clinically and radiographically examined and their eligibility will be
           assessed.

        -  Eligible patients will be randomly assigned to one of 2 groups: experimental group
           (pulpotomy using Biodentine) and the control group (pulpotomy using MTA).

        -  After adminsrtation of local anesthesia, pulpotomy will be done under rubber dam
           isolation. The pulp tissue will be removed until the level of the orifices of the
           canals. After hemostasis is achieved, the capping material will be placed. In the
           experimental group, the capping material is Biodentine while in the control group, the
           capping material is MTA

        -  The cavities will be sealed with resin-modified glass ionomer. Then the teeth will be
           permanently restored with composite . A post-operative radiograph will be taken.

        -  The patients will be given a pain diary based on Numerical Rating Scale (NRS) and asked
           to rate their pain level at the specified times.

        -  The patients will be recalled after 6 and 12 months post-operatively.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2019</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Type: Two arm, parallel, randomized clinical trial. Allocation ratio: 1:1 Framework: Superiority.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>The study will be participant-blind where the participant will not know the intervention done.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain after 6 hours postoperatively</measure>
    <time_frame>6 hours postoperatively</time_frame>
    <description>Each patient will be given a pain diary based on Numerical Rating Scale(NRS). NRS is an 11-point scale consisting of numbers from 0 through 10.
0 reading represents &quot;no pain&quot;
1- 3 readings represent &quot;mild pain&quot;
4- 6 readings represent &quot;moderate pain&quot;
7- 10 readings represent &quot;severe pain&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain after 12 hours postoperatively</measure>
    <time_frame>12 hours postoperatively</time_frame>
    <description>Each patient will be given a pain diary based on Numerical Rating Scale(NRS). NRS is an 11-point scale consisting of numbers from 0 through 10.
0 reading represents &quot;no pain&quot;
1- 3 readings represent &quot;mild pain&quot;
4- 6 readings represent &quot;moderate pain&quot;
7- 10 readings represent &quot;severe pain&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain after 24 hours postoperatively</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Each patient will be given a pain diary based on Numerical Rating Scale(NRS). NRS is an 11-point scale consisting of numbers from 0 through 10.
0 reading represents &quot;no pain&quot;
1- 3 readings represent &quot;mild pain&quot;
4- 6 readings represent &quot;moderate pain&quot;
7- 10 readings represent &quot;severe pain&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall (clinical and radiographic) success after 6 months postoperatively.</measure>
    <time_frame>6 months postoperatively</time_frame>
    <description>Outcome of overall success will be determined based on clinical and radiographic examination. If there is either clinical or radiographic failure , then the case will be considered as an overall failure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall (clinical and radiographic) success after 12 months postoperatively.</measure>
    <time_frame>12 months postoperatively</time_frame>
    <description>Outcome of overall success will be determined based on clinical and radiographic examination. If there is either clinical or radiographic failure , then the case will be considered as an overall failure.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Symptomatic Irreversible Pulpitis</condition>
  <arm_group>
    <arm_group_label>Mineral Trioxide Aggregate (MTA)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Biodentine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MTA Pulpotomy.</intervention_name>
    <description>Pulpotomy using MTA.</description>
    <arm_group_label>Mineral Trioxide Aggregate (MTA)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biodentine Pulpotomy</intervention_name>
    <description>Pulpotomy using Biodentine</description>
    <arm_group_label>Biodentine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aging between 18-40 years old

          -  Patients with symptomatic irreversible pulpitis.

          -  Radiographically: Absence or slight widening in periodontal ligament space.

          -  Systemically- healthy patients (ASA I or II).

          -  Patients who agree to attend for recall appointments and provide written consent.

        Exclusion Criteria:

          -  Severe marginal periodontitis.

          -  Necrotic pulp, pulp polyp, tooth tender to percussion, clinical progression into
             periapical abscess, fistula.

          -  Non-restorable teeth, teeth with internal/external root resorption or root canal
             calcification.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Youssef A. Kamal Elalfy, B.D.S.</last_name>
    <role>Principal Investigator</role>
    <affiliation>faculty of dentistry Cairo university</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Youssef A. Kamal Elalfy, B.D.S</last_name>
    <phone>+201286069484</phone>
    <email>Youssef_Andraws@dentistry.cu.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Suzan AW Amin, Ph.D.</last_name>
    <email>swaness@rocketmail.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Asgary S, Eghbal MJ, Fazlyab M, Baghban AA, Ghoddusi J. Five-year results of vital pulp therapy in permanent molars with irreversible pulpitis: a non-inferiority multicenter randomized clinical trial. Clin Oral Investig. 2015 Mar;19(2):335-41. doi: 10.1007/s00784-014-1244-z. Epub 2014 Apr 27.</citation>
    <PMID>24771228</PMID>
  </reference>
  <reference>
    <citation>Galani M, Tewari S, Sangwan P, Mittal S, Kumar V, Duhan J. Comparative Evaluation of Postoperative Pain and Success Rate after Pulpotomy and Root Canal Treatment in Cariously Exposed Mature Permanent Molars: A Randomized Controlled Trial. J Endod. 2017 Dec;43(12):1953-1962. doi: 10.1016/j.joen.2017.08.007. Epub 2017 Oct 20.</citation>
    <PMID>29061359</PMID>
  </reference>
  <reference>
    <citation>Bakhtiar H, Nekoofar MH, Aminishakib P, Abedi F, Naghi Moosavi F, Esnaashari E, Azizi A, Esmailian S, Ellini MR, Mesgarzadeh V, Sezavar M, About I. Human Pulp Responses to Partial Pulpotomy Treatment with TheraCal as Compared with Biodentine and ProRoot MTA: A Clinical Trial. J Endod. 2017 Nov;43(11):1786-1791. doi: 10.1016/j.joen.2017.06.025. Epub 2017 Aug 16.</citation>
    <PMID>28822566</PMID>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 17, 2019</study_first_submitted>
  <study_first_submitted_qc>March 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2019</study_first_posted>
  <last_update_submitted>March 25, 2019</last_update_submitted>
  <last_update_submitted_qc>March 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Youssef Andraws</investigator_full_name>
    <investigator_title>Postgraduate Student, Department of Endodontics, Faculty of Dentistry, Cairo University</investigator_title>
  </responsible_party>
  <keyword>Pulpotomy</keyword>
  <keyword>Mineral Trioxide Aggregate (MTA)</keyword>
  <keyword>Biodentine</keyword>
  <keyword>Vital pulp therapy</keyword>
  <keyword>Postoperative pain</keyword>
  <keyword>Overall success</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulpitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

